{"nct_id":"NCT02720523","title":"A Study to Compare Upadacitinib (ABT-494) to Placebo in Adults With Rheumatoid Arthritis (RA) Who Are on a Stable Dose of Conventional Synthetic Disease-Modifying Anti-Rheumatic Drugs (csDMARDs) and Have an Inadequate Response to csDMARDs","status":"COMPLETED","status_verified_date":"2023-06","start_date":"2016-03-22","start_date_type":"ACTUAL","primary_completion_date":"2017-08-03","primary_completion_date_type":"ACTUAL","completion_date":"2022-06-07","completion_date_type":"ACTUAL","phases":["PHASE2","PHASE3"],"tickers":["ABBV"]}